Given the time lapse & what happened w/ Bachem & Imugene one would tend to think that Assuming you read this eTheRNA raises EUR 34 million in Series B financing to accelerate multiple mRNA therapeutic development programs through to clinical proof of concept https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156307843 but yah, Mr K is a couple days away from being beyond another one of our time lines again